Tarsus Pharmaceuticals, Inc. financial statements, including revenue, expenses, profit, and loss

The total revenue of TARS for the last quarter is 40.81 M USD, and it's 47.80% higher compared to the previous quarter. The net income of Q2 24 is -33.29 M USD.